Acamprosate calcium vs Buprenorph hydrochloride/naloxone hydrochloride
National NHS prescribing compared (Prescription Cost Analysis)
Acamprosate calcium was dispensed 2,872.4× as often as Buprenorph hydrochloride/naloxone hydrochloride in May 2026 — 14,362 items versus 5 in England.
14,362items
Acamprosate calcium · May 2026
NHSBSA Prescription Cost Analysis
5items
Buprenorph hydrochloride/naloxone hydrochloride · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Acamprosate calcium versus Buprenorph hydrochloride/naloxone hydrochloride: national items dispensed by month
▬ Acamprosate calcium · ╌ Buprenorph hydrochloride/naloxone hydrochloride
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Acamprosate calcium | Buprenorph hydrochloride/naloxone hydrochloride |
|---|---|---|
| Items, May 2026 | 14,362 | 5 |
| Items, last 12 months | 173,682 | 2,126 |
| Net ingredient cost, May 2026 | £183,248 | £349 |
See the full profile for Acamprosate calcium or Buprenorph hydrochloride/naloxone hydrochloride.